Edwards Lifesciences (EW) Construction in Progress (2023 - 2025)

Edwards Lifesciences has reported Construction in Progress for 3 years, with the latest figure at $301.2 million in Q4 2025.

• For the quarter ending Q4 2025, Construction in Progress rose 23.44% year-over-year to $301.2 million; the trailing twelve-month figure through Dec 2025 stood at $301.2 million (up 23.44% YoY), and the FY2025 full-year result was $301.2 million, up 23.44% from the prior year.
• Construction in Progress for Q4 2025 stood at $301.2 million, up from $244.0 million in the prior quarter.
• The five-year high for Construction in Progress was $301.2 million in Q4 2025, with the low at $244.0 million in Q4 2024.
• Average Construction in Progress over 3 years is $279.2 million, with a median of $292.5 million recorded in 2023.
• Year-over-year, Construction in Progress declined 16.58% in 2024 and gained 23.44% in 2025.
• Tracing EW's Construction in Progress over 3 years: stood at $292.5 million in 2023, then decreased by 16.58% to $244.0 million in 2024, then gained by 23.44% to $301.2 million in 2025.
• The last three Construction in Progress figures came in at $301.2 million (Q4 2025), $244.0 million (Q4 2024), and $292.5 million (Q4 2023), per Business Quant data.

Peer Comparison